Delta variant establishes more than 6% of tested COVID-19 cases with virus variant in NYC: Health division Kumar Jeetendra | June 19, 2021 The Delta variant, first detected in India, constituted over 6 per cent of COVID-19 cases tested for virus variants in New York City, according to official data from the city’s health department. The New York City Health Department said in its recent update that out of the 105 NYC COVID-19 cases tested for variant viruses …
New programming created to help recognize patients requiring ventilator support: Govt Kumar Jeetendra | June 19, 2021 The government on Saturday said that a new software — Covid Severity Score — has been developed to identify patients who require ventilator support as well as detect emergency and intensive care unit needs early. The software consists of an algorithm that measures a set of parameters, and then identifies patients likely to require ventilator …
AstraZeneca vaccine’s investigator backs India’s 12–16-week Covishield dose gap Kumar Jeetendra | June 19, 2021 Backing the 12-16 weeks gap between the two doses of Covishield in India, the chief investigator of the AstraZeneca vaccine clinical trials on June 18 said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab. In an interview with The Wire, …
UK opens up COVID-19 vaccines to all adults in final push’ for protection Kumar Jeetendra | June 18, 2021 The UK’s health officials on Friday opened up the country’s COVID-19 vaccination programme to all adults, in what has been dubbed as the “final push” to offer protection against the deadly virus. The National Health Service (NHS) said everyone aged 18 and over is being urged to arrange a jab if they have not had …
Perlara partners with Vivan Therapeutics to tackle rare genetic diseases Kumar Jeetendra | June 17, 2021 Berkeley, California, London, United Kingdom – June 17, 2021 – – Perlara PBC, a rare disease public benefit company today announced a rare genetic diseases collaboration with Vivan Therapeutics to identify novel therapeutics for rare genetic diseases. Under this agreement, Perlara will refer highly motivated patients, families and foundations seeking to embark on a discovery …
Which COVID vaccine is ideal? Here’s the reason that is truly difficult to reply Kumar Jeetendra | June 17, 2021 With the rollout of COVID-19 vaccines accelerating, people are increasingly asking which vaccine is best? Even if we tried to answer this question, defining which vaccine is “best” is not simple. Does that mean the vaccine better at protecting you from serious disease? The one that protects you from whichever variant is circulating near you? …
Weight-based dosing procedure may influence immunotherapy results, shows study Kumar Jeetendra | June 15, 2021 Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center. The findings, published in the Journal for ImmunoTherapy of Cancer, run counter to current practice trends, which favor fixed dosing, in which …
WHO chief Tedros Adhanom Ghebreyesus says vaccine need surpasses G7 vows Kumar Jeetendra | June 13, 2021 The head of the World Health Organisation has welcomed the vaccine-sharing announcements coming out of the Group of Seven summit but says “we need more, and we need them faster.” “The challenge, I said to the G-7 leaders, was that to truly end the pandemic, our goal must be to vaccinate at least 70% of …
World Blood Donor Day 2021 Kumar Jeetendra | June 13, 2021 The WHO South-East Asia Region continues to accelerate action to ensure that everyone, everywhere has timely access to sufficient and secure blood and blood products, and safe transfusion services. Blood transfusions are required to treat and manage a range of health conditions that people from all countries, of all incomes, experience, from thalassemia and haemophilia, …
New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian disease Kumar Jeetendra | June 12, 2021 Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced effective results, dramatically restricting tumor growth and diminishing tumor mass. Designed especially for ovarian cancers that are resistant to conventional therapies, the new radiopharmaceutical could be produced in 25 minutes at reduced cost, which contributes to better efficiency compared with alternative procedures. This …
Administrative gesture for conducting clinical trials of Colchicine on COVID-19 patients: CSIR Kumar Jeetendra | June 12, 2021 The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday. Ram Vishwakarma, the advisor to the CSIR Director General, said Colchicine in combination with standard care will be an important therapeutic …
MFine to Vaccinate 5 million Indians as Part of Covid-19 Vaccination Program for Corporates Kumar Jeetendra | June 11, 2021 Bengaluru, 10 June 2021: India’s leading Digital Health startup MFine today announced the launch of their corporate vaccination program for corporates across the country. Being the largest digital health platform in India with over 600 trusted hospitals on its platform, MFine has partnered with over 100 corporates for safe and swift vaccination drives for employees …
